drugset / Trial / NCT04664153

Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis

NCT04664153

Phase 2 Completed 104 enrolled Pfizer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is being conducted to provide data on efficacy, safety, tolerability and PK of PF-07038124 ointment versus vehicle control in the treatment of mild to moderate AD and mild to moderate plaque psoriasis.

Timeline

Start
2020-12-21
Primary completion
2021-08-18
Completion
2021-08-18

Drugs

EvaluationDrugModalityDoseRoute
Subject IDREBORMILAST Small molecule 0.01 % Topical

Indications